Bristol Myers Free Cash Flow per Share Over Time

BMY Stock  USD 53.25  0.70  1.33%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bristol Myers Performance and Bristol Myers Correlation.
  
Free Cash Flow Per Share is likely to rise to 6.42 in 2024.
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.09)
Dividend Share
2.31
Earnings Share
3.86
Revenue Per Share
21.753
Quarterly Revenue Growth
0.006
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Free Cash Flow Per Share Analysis

Compare Bristol-Myers Squibb and related stocks such as Agilent Technologies, Mustang Bio, and Moleculin Biotech Free Cash Flow per Share Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
A0.76962.97412.80651.51951.18022.00612.21432.83492.75482.59554.26323.41475.01364.514.74
MBIO(2.361)(2.361)(2.361)(2.361)(2.361)(2.361)(2.361)(9.3536)(15.1334)(15.505)(11.903)(10.0756)(9.8825)(5.7635)(6.05)
MBRX(2.3117)(2.3117)(2.3117)(2.3117)(2.3117)(2.3117)(2.3117)(2.3755)(2.9231)(2.5417)(1.8431)(0.7058)(0.9686)(12.262)(11.65)
CLVRW(214)(214)(214)(214)(214)(214)(214)(214)(214)(214)(71.0809)(50.813)(23.7329)(21.36)(22.43)
MCRB(0.1555)(0.1555)(0.1555)(0.1845)(0.3814)(1.921)0.5629(1.9827)(1.5902)(1.3685)(1.1806)(0.0314)(2.208)(0.9791)(1.03)
MDGL(39.0492)(35.5882)(32.1896)(38.5527)(28.099)(418)(3.3837)(1.8328)(1.7253)(2.715)(10.222)(11.1354)(13.1337)(17.429)(18.3)
EQ(0.6203)(0.6203)(0.6203)(0.6203)(0.6203)(0.6203)(0.6203)(0.6203)(0.6203)(1.3248)(1.2196)(1.1157)(0.2672)(0.6287)(0.66)
KA(143)(143)(143)(143)(143)(143)(143)(143)(143)(143)0.0328(4.0966)(3.8774)(1.4663)(1.54)
ME(0.3099)(0.3099)(0.3099)(0.3099)(0.3099)(0.3099)(0.3099)(0.3099)(0.3099)(0.6382)(0.2008)(0.5001)(0.3913)(0.45)(0.47)

Bristol-Myers Squibb and related stocks such as Agilent Technologies, Mustang Bio, and Moleculin Biotech Free Cash Flow Per Share description

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

My Equities

My Current Equities and Potential Positions

Bristol Myers Squibb
BMY
Bristol Myers Fama & French Healthcare
Healthcare
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
USD 53.25
When determining whether Bristol-Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:
Check out Bristol Myers Performance and Bristol Myers Correlation.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bristol Myers technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bristol Myers trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...